GSRX Industries Inc. (GSRX) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGSRX Industries Inc. (GSRX) trades at $0.0001. GSRX Industries Inc. operates six retail cannabis dispensaries across Puerto Rico and California, alongside an e-commerce platform for hemp extract products. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for GSRX: GSRX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
GSRX Industries Inc. (GSRX) Healthcare & Pipeline Overview
GSRX Industries Inc. is a healthcare sector entity specializing in the retail distribution of cannabis through six dispensaries in Puerto Rico and California, complemented by an e-commerce platform for hemp extracts. The company also engages in the extraction, manufacturing, and distribution of cannabis and cannabinoid products, positioning itself within the evolving legal cannabis market.
What Is the Investment Thesis for GSRX?
GSRX Industries Inc. presents an investment profile centered on its operational footprint in the expanding legal cannabis markets of Puerto Rico and California, alongside its e-commerce presence for hemp extracts. The company's current operations include six retail dispensaries and an integrated focus on extraction, manufacturing, and distribution, which could provide long-term supply chain control. Financially, GSRX operates with a negative profit margin of -329.5% and a gross margin of 44.8%, indicating significant operational costs relative to revenue, necessitating careful evaluation of its path to profitability. The market capitalization is reported as $0.00B, and free cash flow is also $0.00B, suggesting a company in an early or transitional stage with limited financial scale. The reported Beta of -34.87 is an anomalous figure that may reflect extreme volatility or limited correlation data rather than a true market hedge. Key growth catalysts include potential expansion of its dispensary network and increased penetration of its e-commerce platform. However, the company's small scale, significant unprofitability, and reliance on a highly regulated industry present considerable risks that require thorough due diligence.
Based on FMP financials and quantitative analysis
GSRX Key Highlights
GSRX Industries Inc. operates six retail cannabis dispensaries, with five in Puerto Rico and one in California, establishing a multi-state operational base.
- The company maintains a significant negative profit margin of -329.5%, highlighting substantial operational costs relative to its revenue generation.
- A gross margin of 44.8% indicates that while direct costs of goods sold are managed, overhead and other expenses are currently outweighing gross profits.
- GSRX also owns and operates GetPureAndNatural.com, an e-commerce platform for hemp extract products, diversifying its revenue streams beyond physical dispensaries.
- The company is actively involved in the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products, aiming for vertical integration within the supply chain.
Who Are GSRX's Competitors?
GSRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $20.9M | — |
| AYTU Aytu BioPharma, Inc. | $2.04 | -1.45% | $21.9M | — |
| TXMD TherapeuticsMD, Inc. | $2.01 | -1.95% | $24.0M | — |
| CPHI CPHI | $0.65 | -0.61% | $27.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GSRX's Key Strengths?
Operational footprint with six established cannabis dispensaries across Puerto Rico and California.
- Diversified business model including both retail cannabis and e-commerce for hemp extracts.
- Focus on vertical integration (extraction, manufacturing, distribution) to control product quality and supply.
- Headquartered in Dorado, Puerto Rico, potentially leveraging local market insights.
What Are GSRX's Weaknesses?
Significant negative profit margin of -329.5% indicates substantial unprofitability.
- Small employee base of 4, potentially limiting scalability and operational capacity.
- Market capitalization and free cash flow reported as $0.00B, suggesting limited financial scale and resources.
- Operating in a highly regulated industry with varying state and federal legal statuses.
What Are the Key Risks for GSRX?
Financial-distress signal — its Altman Z-Score of -19.77 sits in the distress zone (elevated bankruptcy risk).
- Significant unprofitability, as evidenced by a -329.5% profit margin, posing challenges for sustained operations and future investment.
- High regulatory complexity and evolving legal frameworks in the cannabis industry across different jurisdictions, impacting operational stability.
- Intense competition from larger, better-capitalized multi-state operators in both the retail and manufacturing segments of the cannabis market.
- Limited financial resources and capital access, given its $0.00B market cap and OTC 'Unknown' disclosure status, hindering growth and expansion plans.
- Operational risks associated with a small employee base of 4, which may limit the company's ability to scale effectively or manage complex operations.
What Threats Does GSRX Face?
- Intense competition from larger, well-funded multi-state operators in the cannabis industry.
- Evolving and unpredictable regulatory changes at both federal and state levels.
- Challenges in securing capital for expansion given its current financial metrics and OTC status.
- Reputational risks associated with the nascent and often stigmatized cannabis industry.
What Are GSRX's Competitive Advantages?
- Established retail presence with six operating dispensaries across two distinct legal cannabis markets (Puerto Rico and California).
- Vertical integration strategy encompassing extraction, manufacturing, distribution, and retail, potentially offering greater control over product quality and supply chain efficiency.
- Diversified revenue streams through both physical dispensaries and an e-commerce platform for hemp-derived products.
- Early mover advantage in specific regional markets, particularly in Puerto Rico, where it operates five dispensaries under the 'Green Spirit RX' brand.
What Does GSRX Do?
GSRX Industries Inc., headquartered in Dorado, Puerto Rico, operates within the specialized segment of the healthcare sector, focusing on the burgeoning cannabis and cannabinoid product market. The company's primary business revolves around the acquisition, development, and operation of retail cannabis dispensaries. Currently, GSRX manages a portfolio of six dispensaries, with five operating under the 'Green Spirit RX' brand across various locations in Puerto Rico, and one dispensary named 'The Green Room' situated in California. This dual-geographic retail footprint allows GSRX to tap into distinct regional cannabis markets, each with its own regulatory framework and consumer base. Beyond its retail operations, GSRX Industries Inc. has diversified its business model to include an e-commerce platform, GetPureAndNatural.com, which offers a selection of hemp extract products. This online presence provides an additional revenue stream and broadens the company's reach beyond its physical dispensary locations, catering to consumers interested in non-THC cannabinoid products. Furthermore, the company is actively involved in the vertical integration of its cannabis operations, with a strategic focus on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. This integrated approach aims to control the supply chain from raw material to end-product, potentially enhancing product quality, consistency, and margin capture. The company was initially incorporated as Green Spirit Industries Inc. and underwent a name change to GSRX Industries Inc. in July 2018, reflecting its evolving corporate identity and strategic direction within the industry. With a lean operational structure, managing 4 employees, GSRX navigates the complexities of a highly regulated and rapidly developing market, aiming to establish and expand its presence in both the retail and supply chain segments of the cannabis industry.
What Products and Services Does GSRX Offer?
- Acquires, develops, and operates retail cannabis dispensaries.
- Operates five 'Green Spirit RX' cannabis dispensaries in Puerto Rico.
- Operates one 'The Green Room' cannabis dispensary in California.
- Manages GetPureAndNatural.com, an e-commerce site for hemp extract products.
- Engages in the extraction of cannabis and cannabinoid products.
- Manufactures various cannabis and cannabinoid products.
- Distributes and delivers cannabis and cannabinoid products to market.
How Does GSRX Make Money?
- Retail sales of cannabis products through physical dispensaries in Puerto Rico and California.
- E-commerce sales of hemp extract products via GetPureAndNatural.com.
- Wholesale and direct sales of extracted, manufactured, and delivered cannabis and cannabinoid products to other businesses or consumers.
What Industry Does GSRX Operate In?
GSRX Industries Inc. operates within the 'Drug Manufacturers - Specialty & Generic' industry, specifically targeting the legal cannabis and cannabinoid product market. This sector is characterized by evolving regulatory landscapes, varying state-level legality, and a dynamic competitive environment. The global legal cannabis market is experiencing significant growth driven by increasing legalization for medicinal and recreational use, alongside rising consumer acceptance of cannabinoid-based products. GSRX's strategy of operating retail dispensaries in Puerto Rico and California positions it in two distinct, yet growing, regional markets. The competitive landscape includes numerous multi-state operators (MSOs), smaller regional players, and e-commerce platforms. GSRX's relatively small operational footprint and focus on vertical integration for extraction and manufacturing aim to carve out a niche by controlling product quality and supply, differentiating it from purely retail-focused competitors.
Who Are GSRX's Key Customers?
- Medical cannabis patients in Puerto Rico requiring prescribed cannabis products.
- Adult-use recreational cannabis consumers in California.
- Consumers seeking hemp extract products through its e-commerce platform.
- Potential wholesale clients for its extracted and manufactured cannabinoid products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
GSRX Industries Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Dorado, US. The company is led by CEO Troy Nihart. GSRX has traded publicly since 2007.
Financial Health
GSRX Industries Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -19.77 places it in the distress zone, a signal of elevated financial risk.
GSRX Financials
GSRX Latest News
GSRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GSRX.
Price Targets
Wall Street price target analysis for GSRX.
GSRX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GSRX; grades run from A+ (80-100) to F (below 30).
Leadership: Troy Nihart
Chief Executive Officer
Troy Nihart currently serves as the Chief Executive Officer of GSRX Industries Inc. This suggests a hands-on approach to operations within the company's current scale, overseeing its retail cannabis dispensaries, e-commerce platform, and vertical integration efforts in the cannabis and cannabinoid product space.
Track Record: Under Troy Nihart's leadership, GSRX Industries Inc. has maintained its operational footprint, including six retail cannabis dispensaries in Puerto Rico and California. His tenure has seen the continued operation of the GetPureAndNatural.com e-commerce site and the ongoing focus on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. Specific achievements or strategic decisions beyond these operational continuities are not detailed in the provided information.
GSRX OTC Market Information
GSRX Industries Inc. trades on the 'OTC Other' tier of the OTC market. This tier is typically for companies that do not meet the minimum disclosure requirements for OTCQX or OTCQB, or that choose not to provide financial information to OTC Markets Group. Companies in this tier are not required to report to the SEC, and their financial information may be limited or difficult to access. This classification generally indicates a higher level of risk and less transparency compared to companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers.
- OTC Tier: OTC Other
- Limited Transparency: 'Unknown' disclosure status means critical financial and operational information may not be readily available, hindering informed investment decisions.
- Low Liquidity: Trading on the 'OTC Other' tier often results in low trading volumes and wide bid-ask spreads, making it difficult to enter or exit positions efficiently.
- Price Volatility: OTC stocks, especially those with limited information and low liquidity, are prone to extreme price fluctuations.
- Regulatory Scrutiny: Companies in the cannabis sector, particularly those on OTC markets, may face increased regulatory scrutiny and compliance challenges.
- Limited Access to Capital: The lack of transparency and low market profile can make it difficult for the company to raise capital for growth or operational needs.
- Verify the latest available financial statements and audit reports, if any, directly from the company or regulatory filings.
- Research any news or press releases from the company regarding its operations, expansion plans, and financial performance.
- Investigate the backgrounds and track records of key management personnel beyond what is publicly stated.
- Assess the competitive landscape in Puerto Rico and California for cannabis dispensaries and hemp product e-commerce.
- Understand the specific state and local regulations governing cannabis operations in its markets and the company's compliance.
- Evaluate the company's capital structure, debt levels, and ability to secure future funding.
- Monitor trading volumes and bid-ask spreads to gauge actual market liquidity before considering any investment.
- Operates six physical retail cannabis dispensaries, indicating tangible assets and operational presence.
- Maintains an active e-commerce platform, GetPureAndNatural.com, demonstrating an online business presence.
- Engages in vertical integration activities (extraction, manufacturing, distribution), suggesting a comprehensive business strategy.
- Has a stated headquarters in Dorado, Puerto Rico, providing a physical base of operations.
Common Questions About GSRX (Healthcare)
What does GSRX Industries Inc. do?
GSRX Industries Inc. is primarily engaged in the legal cannabis and cannabinoid product market. The company operates six retail cannabis dispensaries: five under the 'Green Spirit RX' brand in Puerto Rico and one named 'The Green Room' in California.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial metrics like Market Cap and FCF being $0.00B suggest either extremely small values or potentially outdated/unavailable data, which impacts the depth of financial analysis.
- The Beta value of -34.87 is highly unusual and may indicate data anomalies or extreme volatility rather than a reliable market correlation.
- Limited specific information on CEO background and track record required inference based on company operations and employee count.
- The 'Unknown' disclosure status for OTC analysis implies significant data limitations for investors.